Dowling & Yahnke’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.51M | Sell |
41,341
-1,087
| -3% | -$69.4K | 0.12% | 153 |
|
|
2022
Q2 | $2.66M | Sell |
42,428
-826
| -2% | -$54.7K | 0.13% | 152 |
|
|
2022
Q1 | $3.04M | Sell |
43,254
-2,272
| -5% | -$154K | 0.13% | 148 |
|
|
2021
Q4 | $2.85M | Sell |
45,526
-1,261
| -3% | -$79.1K | 0.14% | 150 |
|
|
2021
Q3 | $2.89M | Sell |
46,787
-2,677
| -5% | -$161K | 0.16% | 145 |
|
|
2021
Q2 | $2.96M | Sell |
49,464
-3,647
| -7% | -$231K | 0.17% | 139 |
|
|
2021
Q1 | $3.23M | Buy |
53,111
+1,052
| +2% | +$58.1K | 0.22% | 125 |
|
|
2020
Q4 | $2.44M | Sell |
52,059
-600
| -1% | -$26K | 0.17% | 139 |
|
|
2020
Q3 | $1.96M | Buy |
52,659
+113
| +0.2% | +$4.29K | 0.16% | 143 |
|
|
2020
Q2 | $1.92M | Buy |
52,546
+15,264
| +41% | +$531K | 0.16% | 143 |
|
|
2020
Q1 | $1.14M | Sell |
37,282
-16,559
| -31% | -$734K | 0.11% | 174 |
|
|
2019
Q4 | $2.74M | Buy |
53,841
+1,629
| +3% | +$78.6K | 0.21% | 125 |
|
|
2019
Q3 | $2.46M | Sell |
52,212
-1,155
| -2% | -$55.1K | 0.2% | 128 |
|
|
2019
Q2 | $2.65M | Buy |
53,367
+1,783
| +3% | +$83.8K | 0.22% | 125 |
|
|
2019
Q1 | $2.2M | Buy |
51,584
+315
| +0.6% | +$13.9K | 0.21% | 120 |
|
|
2018
Q4 | $2.29M | Sell |
51,269
-1,497
| -3% | -$64.2K | 0.24% | 110 |
|
|
2018
Q3 | $2.46M | Buy |
52,766
+523
| +1% | +$23.9K | 0.22% | 127 |
|
|
2018
Q2 | $2.28M | Sell |
52,243
-330
| -0.6% | -$15.4K | 0.21% | 130 |
|
|
2018
Q1 | $2.41M | Sell |
52,573
-79
| -0.2% | -$3.83K | 0.23% | 122 |
|
|
2017
Q4 | $2.66M | Buy |
52,652
+393
| +0.8% | +$20.7K | 0.24% | 118 |
|
|
2017
Q3 | $2.71M | Sell |
52,259
-5,849
| -10% | -$285K | 0.28% | 111 |
|
|
2017
Q2 | $2.85M | Sell |
58,108
-163
| -0.3% | -$7.56K | 0.3% | 104 |
|
|
2017
Q1 | $2.74M | Buy |
58,271
+1,423
| +3% | +$67.8K | 0.29% | 104 |
|
|
2016
Q4 | $2.73M | Sell |
56,848
-662
| -1% | -$30.4K | 0.31% | 104 |
|
|
2016
Q3 | $2.28M | Sell |
57,510
-2,735
| -5% | -$103K | 0.27% | 111 |
|
|
2016
Q2 | $2.14M | Buy |
60,245
+3,652
| +6% | +$142K | 0.26% | 113 |
|
|
2016
Q1 | $2.22M | Sell |
56,593
-3,166
| -5% | -$118K | 0.27% | 109 |
|
|
2015
Q4 | $2.57M | Sell |
59,759
-23
| -0% | -$1.01K | 0.32% | 98 |
|
|
2015
Q3 | $2.51M | Buy |
59,782
+3,491
| +6% | +$163K | 0.34% | 97 |
|
|
2015
Q2 | $2.81M | Buy |
56,291
+231
| +0.4% | +$10.9K | 0.35% | 93 |
|
|
2015
Q1 | $2.53M | Sell |
56,060
-211
| -0.4% | -$9.48K | 0.32% | 98 |
|
|
2014
Q4 | $2.71M | Buy |
56,271
+1,265
| +2% | +$60.1K | 0.34% | 96 |
|
|
2014
Q3 | $2.63M | Buy |
55,006
+1,313
| +2% | +$63.8K | 0.35% | 97 |
|
|
2014
Q2 | $2.66M | Buy |
53,693
+735
| +1% | +$34.4K | 0.34% | 95 |
|
|
2014
Q1 | $2.49M | Buy |
52,958
+1,371
| +3% | +$63K | 0.33% | 98 |
|
|
2013
Q4 | $2.48M | Buy |
51,587
+1,627
| +3% | +$72.9K | 0.35% | 95 |
|
|
2013
Q3 | $2.09M | Buy |
49,960
+1,822
| +4% | +$78.5K | 0.33% | 99 |
|
|
2013
Q2 | $1.96M | Buy |
+48,138
| New | +$1.77M | 0.33% | 98 |
|
Other funds holding MET
Dowling & Yahnke's MET Position: Q3 2022 in Review
Dowling & Yahnke reduced its MetLife (MET) stake by 2.6% in Q3 2022, selling an estimated $69.4K and leaving 41,341 shares worth $2.51M. The position accounts for 0.12% of the portfolio, ranked #153.
Dowling & Yahnke first reported a position in MET in Q2 2013 and has held it in 38 quarters since. The position peaked at $3.23M in Q1 2021. 1,195 funds tracked by Wall St. Rank hold MET as of Q3 2022.
- Dowling & Yahnke held 41,341 shares of MetLife worth $2.51M as of Q3 2022.
- Dowling & Yahnke sold 1,087 MetLife shares in Q3 2022, an estimated $69.4K.
- MetLife made up 0.12% of Dowling & Yahnke's portfolio in Q3 2022, its #153 holding.
- Dowling & Yahnke first reported a position in MetLife in Q2 2013 and has held it in 38 quarters since.
- Dowling & Yahnke's MetLife position peaked at $3.23M in Q1 2021.
- 1,195 funds tracked by Wall St. Rank held MetLife as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.